United States — Federal Reserve & AstraZeneca
4 shared events · Importance 3 · Last updated Aug 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — Federal Reserve: Held rates steady but signaled uncertainty. Markets pricing in a possible September hike.
AstraZeneca: Investors punished the stock over merger talks with Bristol Myers Squibb.
Jul 14, 2026 · 280 articles
Domestic
United States — Federal Reserve: The United States — Federal Reserve officials remain cautious on rate cuts due to the uncertainty created by the new tariffs, despite pressure from Donald Trump to cut rates more aggressively.
AstraZeneca: AstraZeneca, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
International
United States — Federal Reserve: The Fed faces increased rate hike bets due to inflation pressures from higher oil prices. Traders see a 33-36% chance of a hike at the upcoming meeting.
AstraZeneca: AstraZeneca gained 1.3% after topping Q2 profit expectations.
Jul 08, 2026 · 472 articles
International
United States — Federal Reserve: The Fed's rate stance is watched, with inflation data upcoming. Higher oil prices may influence monetary policy.
AstraZeneca: Pharmaceutical company, whose stock gained on higher oil prices.
Jul 28, 2026 · 318 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Federal Reserve and AstraZeneca interact across events, view sentiment trends, and discover connected entities.
Open Dashboard